68Ga-NYM005
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-NYM005, covering 2025-05-21 to 2025-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients [Phase 1, Phase 2]